Revenue
attach_money84M USD
YoY -5.5%
SPRYARS Pharmaceuticals, Inc.$ --
ARS Pharmaceuticals, Inc.
SPRY
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-179M USD
YoY -5720.6%
Net Income
verified-171M USD
YoY -2241.8%
EPS
pie_chart-1.74USD
YoY -2209.1%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress40.6%On Track
Revenue Progress22.7M
Revenue Forecast163.7M
Net Income Progress-60.6M
Net Income Forecast-149.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.